71984 WideScreen® Human Cancer Panel 1
Recommended Products
Overview
| Replacement Information |
|---|
| Description | |||||
|---|---|---|---|---|---|
Performance Characteristics |
Species |
Human, other species not tested |
|
Sample Size |
6 µl |
|
Sample Types
|
Serum, plasma, tissue culture supernatants
|
|
| Linearity % recovery across dilutions |
Dilution 1:10 1:20 1:40 |
Range 91%-111% 92%-103% 93%-111% |
Intra-assay CV |
3%-15% |
|
| Inter-assay CV | 7%-24% |
|
Cross-reactivity
|
Negligible
|
|
Matrix Interference |
Hemoglobin (5mg/ml) 72% to 100% Bilirubin (0.2 mg/ml) 81% to 92% Triglycerides (5mg/ml) 101% to 126% |
|
Analyte |
Standard Range |
Assay LDD |
Average Recovery from Serum |
Average Recovery from EDTA Plasma |
Normal Range* |
AFP |
0.15-333 ng/ml |
0.15 ng/ml |
92% |
101% |
<20 ng/ml |
CA 125 |
0.55-1200 U/ml |
0.30 U/ml |
144% |
131% |
<35 U/ml |
CA 15-3 |
0.18-392 U/ml |
0.18 U/ml |
96% |
108% |
<25 U/ml |
CA 19-9 |
0.15-320 U/ml |
0.15 U/ml |
87% |
98% |
<37 U/ml |
CEA |
0.017-37 ng/ml |
0.017 ng/ml |
76% |
84% |
<5 ng/ml |
Prolactin |
0.017-38 ng/ml |
0.017 ng/ml |
72% |
74% |
<29 ng/ml** |
| *Normal range data from American Cancer Society website, www.cancer.org and other sources. |
| References |
|---|
| Applications |
|---|
| Biological Information |
|---|
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Product Usage Statements |
|---|
| Storage and Shipping Information | |
|---|---|
| Ship Code | Blue Ice Only |
| Toxicity | Standard Handling |
| Storage | +2°C to +8°C |
| Do not freeze | Ok to freeze |
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 71984 | 0 |
Documentation
User Protocols
| Title |
|---|
| TB511 WideScreen® Human Cancer Panel 1 |


